Indeed, it has been shown that some radiomic features can be distinguishing between ER+ versus ER−, PR+ versus PR−, HER2+ versus HER2−, and triple-negative adding new insights into breast cancer imaging [21]. The gene discussed is ERBB2; the disease is breast carcinoma.